Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

Evaluation of Efficacy and Safety of MEDI2070 in Patients With Active, Moderate-to-severe Crohn's Disease.
A Phase 2a Study to Evaluate the Efficacy and Safety of MEDI2070 in Subjects With Moderate to Severe Crohn's Disease Who Have Failed or Are Intolerant to Anti-tumor Necrosis Factor-alpha Therapy
Status: Enrolling
Updated:  12/31/1969
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Evaluation of Efficacy and Safety of MEDI2070 in Patients With Active, Moderate-to-severe Crohn's Disease.
A Phase 2a Study to Evaluate the Efficacy and Safety of MEDI2070 in Subjects With Moderate to Severe Crohn's Disease Who Have Failed or Are Intolerant to Anti-tumor Necrosis Factor-alpha Therapy
Status: Enrolling
Updated: 12/31/1969
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Click here to add this to my saved trials
Evaluation of Efficacy and Safety of MEDI2070 in Patients With Active, Moderate-to-severe Crohn's Disease.
A Phase 2a Study to Evaluate the Efficacy and Safety of MEDI2070 in Subjects With Moderate to Severe Crohn's Disease Who Have Failed or Are Intolerant to Anti-tumor Necrosis Factor-alpha Therapy
Status: Enrolling
Updated:  12/31/1969
Charlotte Gastroenterology and Hepatology
mi
from
Charlotte, NC
Evaluation of Efficacy and Safety of MEDI2070 in Patients With Active, Moderate-to-severe Crohn's Disease.
A Phase 2a Study to Evaluate the Efficacy and Safety of MEDI2070 in Subjects With Moderate to Severe Crohn's Disease Who Have Failed or Are Intolerant to Anti-tumor Necrosis Factor-alpha Therapy
Status: Enrolling
Updated: 12/31/1969
Charlotte Gastroenterology and Hepatology
mi
from
Charlotte, NC
Click here to add this to my saved trials
Evaluation of Efficacy and Safety of MEDI2070 in Patients With Active, Moderate-to-severe Crohn's Disease.
A Phase 2a Study to Evaluate the Efficacy and Safety of MEDI2070 in Subjects With Moderate to Severe Crohn's Disease Who Have Failed or Are Intolerant to Anti-tumor Necrosis Factor-alpha Therapy
Status: Enrolling
Updated:  12/31/1969
Consultants for Clinical Research Inc.
mi
from
Cincinnati, OH
Evaluation of Efficacy and Safety of MEDI2070 in Patients With Active, Moderate-to-severe Crohn's Disease.
A Phase 2a Study to Evaluate the Efficacy and Safety of MEDI2070 in Subjects With Moderate to Severe Crohn's Disease Who Have Failed or Are Intolerant to Anti-tumor Necrosis Factor-alpha Therapy
Status: Enrolling
Updated: 12/31/1969
Consultants for Clinical Research Inc.
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Evaluation of Efficacy and Safety of MEDI2070 in Patients With Active, Moderate-to-severe Crohn's Disease.
A Phase 2a Study to Evaluate the Efficacy and Safety of MEDI2070 in Subjects With Moderate to Severe Crohn's Disease Who Have Failed or Are Intolerant to Anti-tumor Necrosis Factor-alpha Therapy
Status: Enrolling
Updated:  12/31/1969
Zeidler Ledcor Centre
mi
from
Edmonton,
Evaluation of Efficacy and Safety of MEDI2070 in Patients With Active, Moderate-to-severe Crohn's Disease.
A Phase 2a Study to Evaluate the Efficacy and Safety of MEDI2070 in Subjects With Moderate to Severe Crohn's Disease Who Have Failed or Are Intolerant to Anti-tumor Necrosis Factor-alpha Therapy
Status: Enrolling
Updated: 12/31/1969
Zeidler Ledcor Centre
mi
from
Edmonton,
Click here to add this to my saved trials
Abuse Potential of Intranasal VYCAVERT Tablets (Hydrocodone Bitartrate/Acetaminophen) in Recreational Opioid Users
A Single-center, Randomized, Double-blind, Active- and Placebo Controlled, 5-way Crossover Study Assessing the Abuse Potential of Intranasally Administered VYCAVERT Tablets in Non-dependent Recreational Opioid Users.
Status: Enrolling
Updated:  12/31/1969
Lifetree Clinical Research
mi
from
Salt Lake City, UT
Abuse Potential of Intranasal VYCAVERT Tablets (Hydrocodone Bitartrate/Acetaminophen) in Recreational Opioid Users
A Single-center, Randomized, Double-blind, Active- and Placebo Controlled, 5-way Crossover Study Assessing the Abuse Potential of Intranasally Administered VYCAVERT Tablets in Non-dependent Recreational Opioid Users.
Status: Enrolling
Updated: 12/31/1969
Lifetree Clinical Research
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Treatment Study of Vitamin D Deficiency in Adolescents
Comparison of Two Standard High-dose Treatment Regimens for Vitamin D Deficiency in Minority Adolescents: Associations of Vitamin D Repletion With Changes in Markers of Musculoskeletal, Cardiometabolic, and Immune Function
Status: Enrolling
Updated:  12/31/1969
Children's Hospital at Montefiore Medical Center
mi
from
Bronx, NY
Treatment Study of Vitamin D Deficiency in Adolescents
Comparison of Two Standard High-dose Treatment Regimens for Vitamin D Deficiency in Minority Adolescents: Associations of Vitamin D Repletion With Changes in Markers of Musculoskeletal, Cardiometabolic, and Immune Function
Status: Enrolling
Updated: 12/31/1969
Children's Hospital at Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Treatment for Non-Alcoholic Fatty Liver With Different Doses of Vitamin E
Treatment for Non-Alcoholic Fatty Liver With Different Doses of Vitamin E
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Treatment for Non-Alcoholic Fatty Liver With Different Doses of Vitamin E
Treatment for Non-Alcoholic Fatty Liver With Different Doses of Vitamin E
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Vitamin D and Vascular Health in Children
Vitamin D and Vascular Function in Obese Children
Status: Enrolling
Updated:  12/31/1969
Primary Care Center, Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Vitamin D and Vascular Health in Children
Vitamin D and Vascular Function in Obese Children
Status: Enrolling
Updated: 12/31/1969
Primary Care Center, Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Primary Sclerosing Cholangitis With Oral Vancomycin by the Study of Its Antimicrobial and Immunomodulating Effects
Treatment of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease Patients With Oral Vancomycin by the Study of Its Antimicrobial and Immunomodulating Effects
Status: Enrolling
Updated:  12/31/1969
Stanford University Medical Center
mi
from
Palo Alto, CA
Primary Sclerosing Cholangitis With Oral Vancomycin by the Study of Its Antimicrobial and Immunomodulating Effects
Treatment of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease Patients With Oral Vancomycin by the Study of Its Antimicrobial and Immunomodulating Effects
Status: Enrolling
Updated: 12/31/1969
Stanford University Medical Center
mi
from
Palo Alto, CA
Click here to add this to my saved trials
trūFreeze® Spray Cryotherapy Patient Registry
trūFreeze® Spray Cryotherapy Patient Registry
Status: Enrolling
Updated:  12/31/1969
Scripps Green Hosptial
mi
from
La Jolla, CA
trūFreeze® Spray Cryotherapy Patient Registry
trūFreeze® Spray Cryotherapy Patient Registry
Status: Enrolling
Updated: 12/31/1969
Scripps Green Hosptial
mi
from
La Jolla, CA
Click here to add this to my saved trials
trūFreeze® Spray Cryotherapy Patient Registry
trūFreeze® Spray Cryotherapy Patient Registry
Status: Enrolling
Updated:  12/31/1969
University of Colorado at Denver
mi
from
Denver, CO
trūFreeze® Spray Cryotherapy Patient Registry
trūFreeze® Spray Cryotherapy Patient Registry
Status: Enrolling
Updated: 12/31/1969
University of Colorado at Denver
mi
from
Denver, CO
Click here to add this to my saved trials
trūFreeze® Spray Cryotherapy Patient Registry
trūFreeze® Spray Cryotherapy Patient Registry
Status: Enrolling
Updated:  12/31/1969
Borland-Groover Clinic
mi
from
Jacksonville, FL
trūFreeze® Spray Cryotherapy Patient Registry
trūFreeze® Spray Cryotherapy Patient Registry
Status: Enrolling
Updated: 12/31/1969
Borland-Groover Clinic
mi
from
Jacksonville, FL
Click here to add this to my saved trials
trūFreeze® Spray Cryotherapy Patient Registry
trūFreeze® Spray Cryotherapy Patient Registry
Status: Enrolling
Updated:  12/31/1969
Ochsner Medical Center
mi
from
Kenner, LA
trūFreeze® Spray Cryotherapy Patient Registry
trūFreeze® Spray Cryotherapy Patient Registry
Status: Enrolling
Updated: 12/31/1969
Ochsner Medical Center
mi
from
Kenner, LA
Click here to add this to my saved trials
trūFreeze® Spray Cryotherapy Patient Registry
trūFreeze® Spray Cryotherapy Patient Registry
Status: Enrolling
Updated:  12/31/1969
University of Maryland
mi
from
Baltimore, MD
trūFreeze® Spray Cryotherapy Patient Registry
trūFreeze® Spray Cryotherapy Patient Registry
Status: Enrolling
Updated: 12/31/1969
University of Maryland
mi
from
Baltimore, MD
Click here to add this to my saved trials
trūFreeze® Spray Cryotherapy Patient Registry
trūFreeze® Spray Cryotherapy Patient Registry
Status: Enrolling
Updated:  12/31/1969
Walter Reed National Military Medical Center
mi
from
Bethesda, MD
trūFreeze® Spray Cryotherapy Patient Registry
trūFreeze® Spray Cryotherapy Patient Registry
Status: Enrolling
Updated: 12/31/1969
Walter Reed National Military Medical Center
mi
from
Bethesda, MD
Click here to add this to my saved trials
trūFreeze® Spray Cryotherapy Patient Registry
trūFreeze® Spray Cryotherapy Patient Registry
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hosptial
mi
from
Boston, MA
trūFreeze® Spray Cryotherapy Patient Registry
trūFreeze® Spray Cryotherapy Patient Registry
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hosptial
mi
from
Boston, MA
Click here to add this to my saved trials
trūFreeze® Spray Cryotherapy Patient Registry
trūFreeze® Spray Cryotherapy Patient Registry
Status: Enrolling
Updated:  12/31/1969
Boston University Medical Center
mi
from
Boston, MA
trūFreeze® Spray Cryotherapy Patient Registry
trūFreeze® Spray Cryotherapy Patient Registry
Status: Enrolling
Updated: 12/31/1969
Boston University Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
trūFreeze® Spray Cryotherapy Patient Registry
trūFreeze® Spray Cryotherapy Patient Registry
Status: Enrolling
Updated:  12/31/1969
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
trūFreeze® Spray Cryotherapy Patient Registry
trūFreeze® Spray Cryotherapy Patient Registry
Status: Enrolling
Updated: 12/31/1969
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
trūFreeze® Spray Cryotherapy Patient Registry
trūFreeze® Spray Cryotherapy Patient Registry
Status: Enrolling
Updated:  12/31/1969
ProHEALTH Care Associates
mi
from
Lake Success, NY
trūFreeze® Spray Cryotherapy Patient Registry
trūFreeze® Spray Cryotherapy Patient Registry
Status: Enrolling
Updated: 12/31/1969
ProHEALTH Care Associates
mi
from
Lake Success, NY
Click here to add this to my saved trials
trūFreeze® Spray Cryotherapy Patient Registry
trūFreeze® Spray Cryotherapy Patient Registry
Status: Enrolling
Updated:  12/31/1969
NYU
mi
from
New York, NY
trūFreeze® Spray Cryotherapy Patient Registry
trūFreeze® Spray Cryotherapy Patient Registry
Status: Enrolling
Updated: 12/31/1969
NYU
mi
from
New York, NY
Click here to add this to my saved trials
trūFreeze® Spray Cryotherapy Patient Registry
trūFreeze® Spray Cryotherapy Patient Registry
Status: Enrolling
Updated:  12/31/1969
University of Rochester/Strong Memorial Medical Center
mi
from
Rochester, NY
trūFreeze® Spray Cryotherapy Patient Registry
trūFreeze® Spray Cryotherapy Patient Registry
Status: Enrolling
Updated: 12/31/1969
University of Rochester/Strong Memorial Medical Center
mi
from
Rochester, NY
Click here to add this to my saved trials
trūFreeze® Spray Cryotherapy Patient Registry
trūFreeze® Spray Cryotherapy Patient Registry
Status: Enrolling
Updated:  12/31/1969
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
trūFreeze® Spray Cryotherapy Patient Registry
trūFreeze® Spray Cryotherapy Patient Registry
Status: Enrolling
Updated: 12/31/1969
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
trūFreeze® Spray Cryotherapy Patient Registry
trūFreeze® Spray Cryotherapy Patient Registry
Status: Enrolling
Updated:  12/31/1969
Ahuja Medical Center-CWR University Hosptials
mi
from
Beachwood, OH
trūFreeze® Spray Cryotherapy Patient Registry
trūFreeze® Spray Cryotherapy Patient Registry
Status: Enrolling
Updated: 12/31/1969
Ahuja Medical Center-CWR University Hosptials
mi
from
Beachwood, OH
Click here to add this to my saved trials
trūFreeze® Spray Cryotherapy Patient Registry
trūFreeze® Spray Cryotherapy Patient Registry
Status: Enrolling
Updated:  12/31/1969
Rhode Island Hospital
mi
from
Providence, RI
trūFreeze® Spray Cryotherapy Patient Registry
trūFreeze® Spray Cryotherapy Patient Registry
Status: Enrolling
Updated: 12/31/1969
Rhode Island Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
trūFreeze® Spray Cryotherapy Patient Registry
trūFreeze® Spray Cryotherapy Patient Registry
Status: Enrolling
Updated:  12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
trūFreeze® Spray Cryotherapy Patient Registry
trūFreeze® Spray Cryotherapy Patient Registry
Status: Enrolling
Updated: 12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Liver Fibrosis in Alpha-1 Antitrypsin Deficiency (Liver AATD)
Clinical Predictors and Epigenetic Markers for Liver Fibrosis in Alpha-1 Antitrypsin Deficiency
Status: Enrolling
Updated:  12/31/1969
Shands at the University of Florida
mi
from
Gainesville, FL
Liver Fibrosis in Alpha-1 Antitrypsin Deficiency (Liver AATD)
Clinical Predictors and Epigenetic Markers for Liver Fibrosis in Alpha-1 Antitrypsin Deficiency
Status: Enrolling
Updated: 12/31/1969
Shands at the University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Low Fat Vegan or American Heart Association Diets & Cardiovascular Risk in Obese 9-18 y.o. With Elevated Cholesterol
Low Fat Vegan Diet or American Heart Association Diet, Impact on Biomarkers of Inflammation, Oxidative Stress and Cardiovascular Risk in Obese 9-18 y.o. With Elevated Cholesterol: A Four Week Randomized Trial
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic
mi
from
Cleveland, OH
Low Fat Vegan or American Heart Association Diets & Cardiovascular Risk in Obese 9-18 y.o. With Elevated Cholesterol
Low Fat Vegan Diet or American Heart Association Diet, Impact on Biomarkers of Inflammation, Oxidative Stress and Cardiovascular Risk in Obese 9-18 y.o. With Elevated Cholesterol: A Four Week Randomized Trial
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Phase III Trial of HMPL-004 in Patients With Mild to Moderate Active Ulcerative Colitis
A Phase III, Randomized, Multi-Centre, Double-Blind, Placebo-Controlled Trial of HMPL-004 in Patients With Mild to Moderate Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Management, Inc.
mi
from
Agawam, MA
A Phase III Trial of HMPL-004 in Patients With Mild to Moderate Active Ulcerative Colitis
A Phase III, Randomized, Multi-Centre, Double-Blind, Placebo-Controlled Trial of HMPL-004 in Patients With Mild to Moderate Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Management, Inc.
mi
from
Agawam, MA
Click here to add this to my saved trials
Eosinophilic Esophagitis Clinical Therapy Comparison Trial
Eosinophilic Esophagitis Clinical Therapy Comparison Trial
Status: Enrolling
Updated:  12/31/1969
Texas Children's Hospital
mi
from
Houston, TX
Eosinophilic Esophagitis Clinical Therapy Comparison Trial
Eosinophilic Esophagitis Clinical Therapy Comparison Trial
Status: Enrolling
Updated: 12/31/1969
Texas Children's Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
A Study of Evacetrapib (LY2484595) in Participants With Hepatic (Liver) Impairment
Pharmacokinetics of Evacetrapib (LY2484595) in Subjects With Hepatic Impairment
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Miami, FL
A Study of Evacetrapib (LY2484595) in Participants With Hepatic (Liver) Impairment
Pharmacokinetics of Evacetrapib (LY2484595) in Subjects With Hepatic Impairment
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
A Study of Evacetrapib (LY2484595) in Participants With Hepatic (Liver) Impairment
Pharmacokinetics of Evacetrapib (LY2484595) in Subjects With Hepatic Impairment
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Orlando, FL
A Study of Evacetrapib (LY2484595) in Participants With Hepatic (Liver) Impairment
Pharmacokinetics of Evacetrapib (LY2484595) in Subjects With Hepatic Impairment
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
Capsule Endoscopy Versus Conservative Therapy for Obscure Gastrointestinal Bleeding
Capsule Endoscopy Versus Conservative Therapy for Obscure Gastrointestinal Bleeding
Status: Enrolling
Updated:  12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Capsule Endoscopy Versus Conservative Therapy for Obscure Gastrointestinal Bleeding
Capsule Endoscopy Versus Conservative Therapy for Obscure Gastrointestinal Bleeding
Status: Enrolling
Updated: 12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Amlexanox for Type 2 Diabetes and Obesity
Clinical Protocol to Investigate the Efficacy of Amlexanox for Treatment of Glucose and Lipid Abnormalities in Obese Type 2 Diabetics
Status: Enrolling
Updated:  12/31/1969
University of Michigan
mi
from
Ann Arbor, MI
Amlexanox for Type 2 Diabetes and Obesity
Clinical Protocol to Investigate the Efficacy of Amlexanox for Treatment of Glucose and Lipid Abnormalities in Obese Type 2 Diabetics
Status: Enrolling
Updated: 12/31/1969
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Efficacy of Secretin MRCP in the Diagnosis and Follow up of Auto Immune Pancreatitis
Efficacy of Secretin Assisted Dynamic MRCP in the Diagnosis and Follow up of Auto Immune Pancreatitis(AIP)
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins Hospital
mi
from
Baltimore, MD
Efficacy of Secretin MRCP in the Diagnosis and Follow up of Auto Immune Pancreatitis
Efficacy of Secretin Assisted Dynamic MRCP in the Diagnosis and Follow up of Auto Immune Pancreatitis(AIP)
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Prospective Study in Patients Undergoing Primary Ventral Hernia Repair Using Parietex™ Composite Ventral Patch
A Multicentre Prospective Study in Patients Undergoing Ventral Hernia Repair by Open Approach With Intraperitoneal Positioning Using Parietex™ Composite Ventral Patch - Panacea Study.
Status: Enrolling
Updated:  12/31/1969
Our Lady of the Lake Regional Medical Center
mi
from
Baton Rouge, LA
A Prospective Study in Patients Undergoing Primary Ventral Hernia Repair Using Parietex™ Composite Ventral Patch
A Multicentre Prospective Study in Patients Undergoing Ventral Hernia Repair by Open Approach With Intraperitoneal Positioning Using Parietex™ Composite Ventral Patch - Panacea Study.
Status: Enrolling
Updated: 12/31/1969
Our Lady of the Lake Regional Medical Center
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
A Prospective Study in Patients Undergoing Primary Ventral Hernia Repair Using Parietex™ Composite Ventral Patch
A Multicentre Prospective Study in Patients Undergoing Ventral Hernia Repair by Open Approach With Intraperitoneal Positioning Using Parietex™ Composite Ventral Patch - Panacea Study.
Status: Enrolling
Updated:  12/31/1969
SurgiCare of MIssouri, P.C.
mi
from
Jefferson City, MO
A Prospective Study in Patients Undergoing Primary Ventral Hernia Repair Using Parietex™ Composite Ventral Patch
A Multicentre Prospective Study in Patients Undergoing Ventral Hernia Repair by Open Approach With Intraperitoneal Positioning Using Parietex™ Composite Ventral Patch - Panacea Study.
Status: Enrolling
Updated: 12/31/1969
SurgiCare of MIssouri, P.C.
mi
from
Jefferson City, MO
Click here to add this to my saved trials
A Prospective Study in Patients Undergoing Primary Ventral Hernia Repair Using Parietex™ Composite Ventral Patch
A Multicentre Prospective Study in Patients Undergoing Ventral Hernia Repair by Open Approach With Intraperitoneal Positioning Using Parietex™ Composite Ventral Patch - Panacea Study.
Status: Enrolling
Updated:  12/31/1969
Monmouth Medical Center
mi
from
Long Branch, NJ
A Prospective Study in Patients Undergoing Primary Ventral Hernia Repair Using Parietex™ Composite Ventral Patch
A Multicentre Prospective Study in Patients Undergoing Ventral Hernia Repair by Open Approach With Intraperitoneal Positioning Using Parietex™ Composite Ventral Patch - Panacea Study.
Status: Enrolling
Updated: 12/31/1969
Monmouth Medical Center
mi
from
Long Branch, NJ
Click here to add this to my saved trials
A Prospective Study in Patients Undergoing Primary Ventral Hernia Repair Using Parietex™ Composite Ventral Patch
A Multicentre Prospective Study in Patients Undergoing Ventral Hernia Repair by Open Approach With Intraperitoneal Positioning Using Parietex™ Composite Ventral Patch - Panacea Study.
Status: Enrolling
Updated:  12/31/1969
Hernia Centers of Excellence
mi
from
Yorktown, VA
A Prospective Study in Patients Undergoing Primary Ventral Hernia Repair Using Parietex™ Composite Ventral Patch
A Multicentre Prospective Study in Patients Undergoing Ventral Hernia Repair by Open Approach With Intraperitoneal Positioning Using Parietex™ Composite Ventral Patch - Panacea Study.
Status: Enrolling
Updated: 12/31/1969
Hernia Centers of Excellence
mi
from
Yorktown, VA
Click here to add this to my saved trials
A Prospective Study in Patients Undergoing Primary Ventral Hernia Repair Using Parietex™ Composite Ventral Patch
A Multicentre Prospective Study in Patients Undergoing Ventral Hernia Repair by Open Approach With Intraperitoneal Positioning Using Parietex™ Composite Ventral Patch - Panacea Study.
Status: Enrolling
Updated:  12/31/1969
University of South Florida
mi
from
Tampa, FL
A Prospective Study in Patients Undergoing Primary Ventral Hernia Repair Using Parietex™ Composite Ventral Patch
A Multicentre Prospective Study in Patients Undergoing Ventral Hernia Repair by Open Approach With Intraperitoneal Positioning Using Parietex™ Composite Ventral Patch - Panacea Study.
Status: Enrolling
Updated: 12/31/1969
University of South Florida
mi
from
Tampa, FL
Click here to add this to my saved trials
A Prospective Study in Patients Undergoing Primary Ventral Hernia Repair Using Parietex™ Composite Ventral Patch
A Multicentre Prospective Study in Patients Undergoing Ventral Hernia Repair by Open Approach With Intraperitoneal Positioning Using Parietex™ Composite Ventral Patch - Panacea Study.
Status: Enrolling
Updated:  12/31/1969
General Surgery - Imelda Hospital
mi
from
Bonheiden,
A Prospective Study in Patients Undergoing Primary Ventral Hernia Repair Using Parietex™ Composite Ventral Patch
A Multicentre Prospective Study in Patients Undergoing Ventral Hernia Repair by Open Approach With Intraperitoneal Positioning Using Parietex™ Composite Ventral Patch - Panacea Study.
Status: Enrolling
Updated: 12/31/1969
General Surgery - Imelda Hospital
mi
from
Bonheiden,
Click here to add this to my saved trials
Effects of Vitamin D Insufficiency in Man
Effects of Vitamin D Insufficiency in Man
Status: Enrolling
Updated:  12/31/1969
UCLA
mi
from
Los Angeles, CA
Effects of Vitamin D Insufficiency in Man
Effects of Vitamin D Insufficiency in Man
Status: Enrolling
Updated: 12/31/1969
UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Bone Marrow Stromal Cells for Inflammatory Bowel Diseases
An Open-Label, Phase 1 Study to Assess the Safety and Tolerability of Bone Marrow Stromal Cell Infusion for the Treatment of Moderate to Severe Inflammatory Bowel Disease
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Bone Marrow Stromal Cells for Inflammatory Bowel Diseases
An Open-Label, Phase 1 Study to Assess the Safety and Tolerability of Bone Marrow Stromal Cell Infusion for the Treatment of Moderate to Severe Inflammatory Bowel Disease
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Study of the Relationship Between Glycogen Storage Disease Type Ia and Inflammatory Bowel Disease
Glycogen Storage Disease Type Ia and Inflammatory Bowel Disease: A New Comorbidity or Secondary Consequence
Status: Enrolling
Updated:  12/31/1969
University of Florida - Shands
mi
from
Gainesville, FL
Study of the Relationship Between Glycogen Storage Disease Type Ia and Inflammatory Bowel Disease
Glycogen Storage Disease Type Ia and Inflammatory Bowel Disease: A New Comorbidity or Secondary Consequence
Status: Enrolling
Updated: 12/31/1969
University of Florida - Shands
mi
from
Gainesville, FL
Click here to add this to my saved trials
Safety Study of Intravenous Immunoglobulin (IVIG) Post-Portoenterostomy in Infants With Biliary Atresia
A Phase 1/2A Trial of Intravenous Immunoglobulin (IVIG) Therapy Following Portoenterostomy in Infants With Biliary Atresia
Status: Enrolling
Updated:  12/31/1969
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Safety Study of Intravenous Immunoglobulin (IVIG) Post-Portoenterostomy in Infants With Biliary Atresia
A Phase 1/2A Trial of Intravenous Immunoglobulin (IVIG) Therapy Following Portoenterostomy in Infants With Biliary Atresia
Status: Enrolling
Updated: 12/31/1969
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety Study of Intravenous Immunoglobulin (IVIG) Post-Portoenterostomy in Infants With Biliary Atresia
A Phase 1/2A Trial of Intravenous Immunoglobulin (IVIG) Therapy Following Portoenterostomy in Infants With Biliary Atresia
Status: Enrolling
Updated:  12/31/1969
Children's Hospital Colorado
mi
from
Aurora, CO
Safety Study of Intravenous Immunoglobulin (IVIG) Post-Portoenterostomy in Infants With Biliary Atresia
A Phase 1/2A Trial of Intravenous Immunoglobulin (IVIG) Therapy Following Portoenterostomy in Infants With Biliary Atresia
Status: Enrolling
Updated: 12/31/1969
Children's Hospital Colorado
mi
from
Aurora, CO
Click here to add this to my saved trials
Safety Study of Intravenous Immunoglobulin (IVIG) Post-Portoenterostomy in Infants With Biliary Atresia
A Phase 1/2A Trial of Intravenous Immunoglobulin (IVIG) Therapy Following Portoenterostomy in Infants With Biliary Atresia
Status: Enrolling
Updated:  12/31/1969
Children's Healthcare of Atlanta
mi
from
Atlanta, GA
Safety Study of Intravenous Immunoglobulin (IVIG) Post-Portoenterostomy in Infants With Biliary Atresia
A Phase 1/2A Trial of Intravenous Immunoglobulin (IVIG) Therapy Following Portoenterostomy in Infants With Biliary Atresia
Status: Enrolling
Updated: 12/31/1969
Children's Healthcare of Atlanta
mi
from
Atlanta, GA
Click here to add this to my saved trials
Safety Study of Intravenous Immunoglobulin (IVIG) Post-Portoenterostomy in Infants With Biliary Atresia
A Phase 1/2A Trial of Intravenous Immunoglobulin (IVIG) Therapy Following Portoenterostomy in Infants With Biliary Atresia
Status: Enrolling
Updated:  12/31/1969
Children's Hospital Medical Center
mi
from
Cincinnati, OH
Safety Study of Intravenous Immunoglobulin (IVIG) Post-Portoenterostomy in Infants With Biliary Atresia
A Phase 1/2A Trial of Intravenous Immunoglobulin (IVIG) Therapy Following Portoenterostomy in Infants With Biliary Atresia
Status: Enrolling
Updated: 12/31/1969
Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Safety Study of Intravenous Immunoglobulin (IVIG) Post-Portoenterostomy in Infants With Biliary Atresia
A Phase 1/2A Trial of Intravenous Immunoglobulin (IVIG) Therapy Following Portoenterostomy in Infants With Biliary Atresia
Status: Enrolling
Updated:  12/31/1969
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Safety Study of Intravenous Immunoglobulin (IVIG) Post-Portoenterostomy in Infants With Biliary Atresia
A Phase 1/2A Trial of Intravenous Immunoglobulin (IVIG) Therapy Following Portoenterostomy in Infants With Biliary Atresia
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Safety Study of Intravenous Immunoglobulin (IVIG) Post-Portoenterostomy in Infants With Biliary Atresia
A Phase 1/2A Trial of Intravenous Immunoglobulin (IVIG) Therapy Following Portoenterostomy in Infants With Biliary Atresia
Status: Enrolling
Updated:  12/31/1969
Children's Hospital of Pittsburgh
mi
from
Pittsburgh, PA
Safety Study of Intravenous Immunoglobulin (IVIG) Post-Portoenterostomy in Infants With Biliary Atresia
A Phase 1/2A Trial of Intravenous Immunoglobulin (IVIG) Therapy Following Portoenterostomy in Infants With Biliary Atresia
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Safety Study of Intravenous Immunoglobulin (IVIG) Post-Portoenterostomy in Infants With Biliary Atresia
A Phase 1/2A Trial of Intravenous Immunoglobulin (IVIG) Therapy Following Portoenterostomy in Infants With Biliary Atresia
Status: Enrolling
Updated:  12/31/1969
Hospital for Sick Children
mi
from
Toronto,
Safety Study of Intravenous Immunoglobulin (IVIG) Post-Portoenterostomy in Infants With Biliary Atresia
A Phase 1/2A Trial of Intravenous Immunoglobulin (IVIG) Therapy Following Portoenterostomy in Infants With Biliary Atresia
Status: Enrolling
Updated: 12/31/1969
Hospital for Sick Children
mi
from
Toronto,
Click here to add this to my saved trials